Below is an educational, technical answer to a question many patients and clinicians ask. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Peripheral Arterial Disease (PAD)
Symptoms range from exertional leg pain (claudication) to, in severe cases, rest pain and non-healing wounds known as critical limb ischemia. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing.
What are the risks of atherectomy?
Reported risks of atherectomy include distal embolization of debris, vessel perforation, and dissection. Embolic protection and careful technique aim to limit these. The benefit of plaque modification is weighed against these risks per lesion. The full risk profile is described in the device IFU.
What This Means in Practice
Access sheath sizing should match the planned devices to limit access-site complications. Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion. Embolic protection is often paired with atherectomy to capture dislodged debris.
Key Considerations
- Access sheath sizing should match the planned devices to limit access-site complications.
- Embolic protection is often paired with atherectomy to capture dislodged debris.
- Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion.
Frequently Asked Questions
Who decides which PAD device to use?
A vascular specialist selects devices based on lesion characteristics; this content is educational and not a treatment recommendation.
What is the regulatory status of these devices?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Is a stent always needed in PAD?
No. Many lesions are treated with angioplasty or drug-coated balloons alone; a stent is added when the vessel recoils or dissects.
Clinical and Technical Context
INVAMED's PTA balloon range is designed to cover common peripheral vessel sizes. Covered stent grafts can be used to exclude certain lesions or manage complications. INVAMED's Extender paclitaxel drug-coated balloon is positioned for this drug-delivery role in peripheral vessels. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. INVAMED's Guardian protection device is designed for this distal-capture role. Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion. Balloon diameter and length are matched to the vessel to avoid over- or under-dilation. Manufacturer figures reflect studied device performance, not guaranteed outcomes. INVAMED's Invaducer introducer sheath sets support the access step of peripheral interventions. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing. Symptoms range from exertional leg pain (claudication) to, in severe cases, rest pain and non-healing wounds known as critical limb ischemia. INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals. Embolic protection is often paired with atherectomy to capture dislodged debris. Use is guided by lesion morphology and clinician preference. Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting. INVAMED's Atlas peripheral stent graft addresses covered-stent applications in the PAD portfolio. Endovascular therapy aims to restore flow through the narrowed segment using balloons, stents, atherectomy, or a combination. Atherectomy is often paired with embolic protection to capture dislodged debris. Appropriate access selection helps reduce access-site complications. Drug dose and balloon sizing follow the device specifications and lesion characteristics.
Related on INVAMED
- Peripheral Arterial Disease (PAD) — product category
- Inside the Guardian Protection Device: Design and Applications
- Choosing a Peripheral Arterial Disease (PAD) Supplier: What Buyers Should Know
- What is atherectomy?
Important Disclaimer
The information here is provided for educational purposes and to describe device technology; it is not a substitute for professional medical advice, diagnosis, or treatment. Only a licensed healthcare provider can determine whether a given procedure or device is appropriate for a specific patient. INVAMED products are restricted to use by qualified professionals following the official IFU. Regulatory clearance and labeling differ between regions, and not all products or indications are available in every market.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.